Categories Earnings, Technology

Earnings Summary: Catalent (CTLT) slips to a loss in Q2; revenue down 10%

Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, on Friday reported a net loss for the second quarter of 2024, reflecting a decline in revenues.

  • Net revenue came in at $1.03 billion in the December quarter, which is down 10% from the prior year quarter
  • The company reported a net loss of $204 million or $1.12 per share for the second quarter, compared to earnings of $81 million or $0.44 per share in Q2 2023
  • On an adjusted basis, loss per share was $0.24 in Q2, vs. a profit of $0.67 per share a year earlier
  • Q2 adjusted EBITDA fell 56% from last year to $124 million as reported, and dropped 57% in constant currency
  • During the quarter, Catalent raised $600 million in term loans and used the proceeds to pay down debt
  • Recently, the company agreed to be acquired by Novo Holdings an all-cash deal that values it at $16.5 billion

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent

Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1

Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three

After a positive year, what’s in the cards for Electronic Arts (EA) in FY25

Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top